Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The bifunctional protein GlmU is a key factor in biofilm formation induced by alkylating stress in Mycobacterium smegmatis.

Di Somma A, Caterino M, Soni V, Agarwal M, di Pasquale P, Zanetti S, Molicotti P, Cannas S, Nandicoori VK, Duilio A.

Res Microbiol. 2019 Jun - Aug;170(4-5):171-181. doi: 10.1016/j.resmic.2019.03.002. Epub 2019 Apr 3.

PMID:
30953691
2.

Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis.

Donadu MG, Usai D, Marchetti M, Usai M, Mazzarello V, Molicotti P, Montesu MA, Delogu G, Zanetti S.

Nat Prod Res. 2019 Jan 24:1-5. doi: 10.1080/14786419.2018.1557175. [Epub ahead of print]

PMID:
30676066
3.

Tuberculides and extrapulmonary TB: an atypical manifestation.

Biondi G, Sotgiu G, Molicotti P, Montesu MA, Puggioni GM, Satta R.

Int J Dermatol. 2019 May;58(5):e102-e103. doi: 10.1111/ijd.14326. Epub 2018 Dec 28. No abstract available.

PMID:
30593656
4.

"In vitro" activity of Melaleuca cajuputi against mycobacterial species.

Bua A, Molicotti P, Donadu MG, Usai D, Le LS, Tran TTT, Ngo VQT, Marchetti M, Usai M, Cappuccinelli P, Zanetti S.

Nat Prod Res. 2018 Dec 5:1-4. doi: 10.1080/14786419.2018.1509335. [Epub ahead of print]

PMID:
30518254
5.

Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.

Carta A, Bua A, Corona P, Piras S, Briguglio I, Molicotti P, Zanetti S, Laurini E, Aulic S, Fermeglia M, Pricl S.

Eur J Med Chem. 2019 Jan 1;161:399-415. doi: 10.1016/j.ejmech.2018.10.031. Epub 2018 Oct 17.

PMID:
30384044
6.

Potential of Borojoa patinoi Cuatrecasas water extract to inhibit nosocomial antibiotic resistant bacteria and cancer cell proliferation in vitro.

Chaves-López C, Usai D, Donadu MG, Serio A, González-Mina RT, Simeoni MC, Molicotti P, Zanetti S, Pinna A, Paparella A.

Food Funct. 2018 May 23;9(5):2725-2734. doi: 10.1039/c7fo01542a.

PMID:
29658045
7.

In vitro activity of hybrid lavender essential oils against multidrug resistant strains of Pseudomonas aeruginosa.

Donadu M, Usai D, Pinna A, Porcu T, Mazzarello V, Fiamma M, Marchetti M, Cannas S, Delogu G, Zanetti S, Molicotti P.

J Infect Dev Ctries. 2018 Jan 31;12(1):9-14. doi: 10.3855/jidc.9920.

8.

Limitations of quantiferon-TB gold assay for screening of psoriasis patients prior to anti-tumour necrotic factor treatment.

Bua A, Zanetti S, Peigottu MF, Montesu MA, Molicotti P.

Infect Dis (Lond). 2018 Apr;50(4):317-319. doi: 10.1080/23744235.2017.1395068. Epub 2017 Oct 26. No abstract available.

PMID:
29069962
9.

Antimicrobial activity of Austroeupatorium inulaefolium (H.B.K.) against intracellular and extracellular organisms.

Bua A, Usai D, Donadu MG, Delgado Ospina J, Paparella A, Chaves-Lopez C, Serio A, Rossi C, Zanetti S, Molicotti P.

Nat Prod Res. 2018 Dec;32(23):2869-2871. doi: 10.1080/14786419.2017.1385014. Epub 2017 Oct 11.

PMID:
29017356
10.

Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?

Biondi G, Sotgiu G, Dore S, Molicotti P, Ruggeri M, Aliberti S, Satta R.

ERJ Open Res. 2017 Sep 19;3(3). pii: 00091-2017. doi: 10.1183/23120541.00091-2017. eCollection 2017 Jul.

11.

Pediatric Tuberculosis in Northern Sardinia.

Clemente MG, Dore E, Abis L, Molicotti P, Zanetti S, Olmeo P, Antonucci R.

Mediterr J Hematol Infect Dis. 2017 Apr 15;9(1):e2017027. doi: 10.4084/MJHID.2017.027. eCollection 2017.

12.

Tuberculosis screening among asylum seekers in Sardinia.

Bua A, Cubeddu M, Piras D, Delogu R, Zanetti S, Molicotti P.

J Public Health (Oxf). 2016 Dec 2;38(4):760-764. doi: 10.1093/pubmed/fdv215. No abstract available.

PMID:
28158527
13.

Change in Caco-2 cells following treatment with various lavender essential oils.

Donadu MG, Usai D, Mazzarello V, Molicotti P, Cannas S, Bellardi MG, Zanetti S.

Nat Prod Res. 2017 Sep;31(18):2203-2206. doi: 10.1080/14786419.2017.1280489. Epub 2017 Jan 23.

PMID:
28114805
14.

Tuberculosis in Sardinia: An investigation into the relationship between natives and immigrants.

Ruggeri M, Molicotti P, Cubeddu M, Cannas S, Bua A, Zanetti S.

Int J Mycobacteriol. 2016 Sep;5(3):280-287. doi: 10.1016/j.ijmyco.2016.06.002. Epub 2016 Jun 27.

15.

Effect of teriflunomide on QuantiFERON-TB Gold results.

Bua A, Ruggeri M, Zanetti S, Molicotti P.

Med Microbiol Immunol. 2017 Feb;206(1):73-75. doi: 10.1007/s00430-016-0482-x. Epub 2016 Oct 4.

PMID:
27704206
16.

Bacterial agents as a cause of infertility in humans.

Ruggeri M, Cannas S, Cubeddu M, Molicotti P, Piras GL, Dessole S, Zanetti S.

New Microbiol. 2016 Jul;39(3):206-209.

17.

QuantiFERON-TB Gold Assay on Plasma for Confirmation of Presumed Tuberculosis-Related Uveitis.

Zanetti S, Bua A, Molicotti P, Maiore I, Pinna A.

J Clin Microbiol. 2016 Aug;54(8):2175-7. doi: 10.1128/JCM.00848-16. Epub 2016 Jun 1.

18.

Chemical composition, cytotoxicity, antimicrobial and antifungal activity of several essential oils.

Cannas S, Usai D, Tardugno R, Benvenuti S, Pellati F, Zanetti S, Molicotti P.

Nat Prod Res. 2016;30(3):332-9. doi: 10.1080/14786419.2015.1060592. Epub 2015 Jul 27.

PMID:
26214364
19.

Essential oils in ocular pathology: an experimental study.

Cannas S, Usai D, Pinna A, Benvenuti S, Tardugno R, Donadu M, Zanetti S, Kaliamurthy J, Molicotti P.

J Infect Dev Ctries. 2015 Jul 4;9(6):650-4. doi: 10.3855/jidc.6842.

20.

Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?

Molicotti P, Bua A, Cubeddu M, Ruggeri M, Mura MS, Pirina P, Zanetti S.

Infect Dis (Lond). 2015 Aug;47(8):563-7. doi: 10.3109/23744235.2015.1031173. Epub 2015 Apr 9.

PMID:
25856090
21.

Mycobacterium tuberculosis infection may provide an antigenic stimulus enabling children to mount a strong immune cell response.

Molicotti P, Bua A, Cannas S, Ruggeri M, Zanetti S.

Infect Dis (Lond). 2015 May;47(5):354-6. doi: 10.3109/00365548.2014.1002000. Epub 2015 Mar 6. No abstract available.

PMID:
25746604
22.

Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.

Tonelli M, Novelli F, Tasso B, Sparatore A, Boido V, Sparatore F, Cannas S, Molicotti P, Zanetti S, Parapini S, Loddo R.

Bioorg Med Chem. 2014 Dec 15;22(24):6837-45. doi: 10.1016/j.bmc.2014.10.035. Epub 2014 Oct 31.

PMID:
25464882
23.

Antifungal, anti-biofilm and adhesion activity of the essential oil of Myrtus communis L. against Candida species.

Cannas S, Molicotti P, Usai D, Maxia A, Zanetti S.

Nat Prod Res. 2014;28(23):2173-7. doi: 10.1080/14786419.2014.925892. Epub 2014 Jun 24.

PMID:
24960256
24.

Cost-effectiveness in the diagnosis of tuberculosis: choices in developing countries.

Molicotti P, Bua A, Zanetti S.

J Infect Dev Ctries. 2014 Jan 15;8(1):24-38. doi: 10.3855/jidc.3295. Review.

25.

Clinical considerations on Buruli ulcer employing two molecular tests for the detection of Mycobacterium ulcerans in 100 skin biopsies.

Leigheb G, Zavattaro E, Molicotti P, Cannas S, Zanetti S, Clemente C, Johnson RC, Sopoh GE, Dossou AD, Colombo E.

Int J Dermatol. 2014 Feb;53(2):213-20. doi: 10.1111/ijd.12249. Epub 2013 Dec 10.

PMID:
24320698
26.

Identification of non-tuberculous mycobacteria from clinical samples.

Molicotti P, Bua A, Cannas S, Cubeddu M, Ruggeri M, Pirina P, Zanetti S.

New Microbiol. 2013 Oct;36(4):409-11. Epub 2013 Oct 1.

27.

Molecular identification of Mycobacterium avium subspecies paratuberculosis in oral biopsies of Crohn's disease patients.

Molicotti P, Scanu AM, Lumbau A, Cannas S, Bua A, Lugliè P, Zanetti S.

Gut Pathog. 2013 Jul 10;5(1):18. doi: 10.1186/1757-4749-5-18.

28.

Tuberculin skin test and QuantiFERON in children.

Bua A, Molicotti P, Cannas S, Ruggeri M, Olmeo P, Zanetti S.

New Microbiol. 2013 Apr;36(2):153-6. Epub 2013 Mar 31.

29.

Antimycotic activity of Myrtus communis L. towards Candida spp. from isolates.

Cannas S, Molicotti P, Ruggeri M, Cubeddu M, Sanguinetti M, Marongiu B, Zanetti S.

J Infect Dev Ctries. 2013 Mar 14;7(3):295-8. doi: 10.3855/jidc.2799. No abstract available.

30.

Chest tuberculosis with mediastinal asymptomatic lymphadenitis without lung involvement in an immunocompetent patient.

Pirina P, Spada V, Santoru L, Polo MF, Molicotti P, Marras V, Cossu Rocca P, Canu S, Zanetti S, Fois AG.

J Infect Dev Ctries. 2013 Mar 14;7(3):280-5. doi: 10.3855/jidc.2973.

31.

In honor of Professor Giovanni Fadda: a fighter against tuberculosis.

Zanetti S, Sechi LA, Molicotti P, Delogu G, Rubino S.

J Infect Dev Ctries. 2013 Mar 14;7(3):159-60. doi: 10.3855/jidc.3499. No abstract available.

32.

Comparison of two molecular methods for diagnosis of Chlamydia trachomatis.

Molicotti P, Usai D, Cubeddu M, Sechi LA, Zanetti S.

J Infect Dev Ctries. 2013 Jan 15;7(1):64-6. doi: 10.3855/jidc.2802. No abstract available.

33.

Sardinian Type 1 diabetes patients, Transthyretin and Mycobacterium avium subspecies paratuberculosis infection.

Masala S, Cossu D, Pacifico A, Molicotti P, Sechi LA.

Gut Pathog. 2012 Dec 27;4(1):24. doi: 10.1186/1757-4749-4-24.

34.

Epidemic of tuberculosis in a high school in Northern Sardinia.

Bua A, Molicotti P, Zanetti A, Ruggeri M, Cubeddu M, Cannas S, Peana N, Sali M, Delogu G, Zanetti S.

Int J Mycobacteriol. 2012 Sep;1(3):161-3. doi: 10.1016/j.ijmyco.2012.07.003. Epub 2012 Aug 15.

35.

Tuberculosis screening before anti-hepatitis C virus therapy in prisons.

Babudieri S, Soddu A, Murino M, Molicotti P, Muredda AA, Madeddu G, Fois AG, Zanetti S, Pirina P, Mura MS.

Emerg Infect Dis. 2012 Apr;18(4):689-91. doi: 10.3201/eid1804.111016. No abstract available.

36.

Performance of QuantiFERON TB in a student population at low risk of tuberculosis.

Molicotti P, Bua A, Zanetti S.

J Infect Dev Ctries. 2012 Jan 12;6(1):100-1. No abstract available.

37.

Interaction between Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium avium subspecies paratuberculosis with the enteric glia and microglial cells.

Cannas S, Molicotti P, Bua A, Usai D, Sechi LA, Scanu AM, Blasi E, Zanetti S.

Gut Pathog. 2011 Dec 9;3:19. doi: 10.1186/1757-4749-3-19.

38.

Tuberculosis patients are characterized by a low-IFN-γ/high-TNF-α response to methylated HBHA produced in M. smegmatis.

Molicotti P, Bua A, Cubeddu M, Cannas S, Delogu G, Zanetti S.

Diagn Microbiol Infect Dis. 2011 Dec;71(4):449-52. doi: 10.1016/j.diagmicrobio.2011.08.010.

PMID:
22083081
39.

Preliminary data of different methods for the indirect diagnosis of Mycobacterium bovis infection.

Molicotti P, Bua A, Cannas S, Ruggeri M, Mura A, Zanetti S.

New Microbiol. 2011 Jul;34(3):323-5. Epub 2011 Jul 30.

40.

Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.

Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, Molicotti P, Zanetti S, Lauria FN, Grisetti S, Magnavita N, Fadda G, Girardi E, Goletti D.

PLoS One. 2011 Mar 29;6(3):e18315. doi: 10.1371/journal.pone.0018315.

41.

Essential oils of Daucus carota subsp. carota of Tunisia obtained by supercritical carbon dioxide extraction.

Marzouki H, Khaldi A, Falconieri D, Piras A, Marongiu B, Molicotti P, Zanetti S.

Nat Prod Commun. 2010 Dec;5(12):1955-8.

PMID:
21299130
42.

Synthesis and anti-mycobacterial activities of triazoloquinolones.

Carta A, Palomba M, Briguglio I, Corona P, Piras S, Jabes D, Guglierame P, Molicotti P, Zanetti S.

Eur J Med Chem. 2011 Jan;46(1):320-6. doi: 10.1016/j.ejmech.2010.11.020. Epub 2010 Nov 19.

PMID:
21145625
43.

Essential oil composition of leaves of Stachys yemenensis obtained by supercritical CO₂.

Ali NA, Marongiu B, Piras A, Porcedda S, Falconieri D, Molicotti P, Zanetti S.

Nat Prod Res. 2010 Nov;24(19):1823-9. doi: 10.1080/14786411003754272.

PMID:
21104527
44.

Evaluation of the Antimicrobial Properties of the Essential Oil of Myrtus communis L. against Clinical Strains of Mycobacterium spp.

Zanetti S, Cannas S, Molicotti P, Bua A, Cubeddu M, Porcedda S, Marongiu B, Sechi LA.

Interdiscip Perspect Infect Dis. 2010;2010. pii: 931530. doi: 10.1155/2010/931530. Epub 2010 Jul 29.

45.

Molecular characterization of Sardinian Mycobacterium tuberculosis isolates by IS6110 restriction fragment length polymorphism, MIRU-VNTR and rep-PCR.

Masala S, Molicotti P, Bua A, Zumbo A, Delogu G, Sechi LA, Zanetti S.

New Microbiol. 2010 Apr;33(2):155-62.

46.

Interferon-γ release assay in people infected with immunodeficiency virus.

Bua A, Molicotti P, Ruggeri M, Madeddu G, Ferrandu G, Mura MS, Zanetti S.

Clin Microbiol Infect. 2011 Mar;17(3):402-4. doi: 10.1111/j.1469-0691.2010.03251.x.

47.

Usefulness of the QuantiFERON-TB-Gold in tube in a population at risk of bovine tubercular infection.

Bua A, Molicotti P, Cannas S, Cubeddu M, Ruggeri M, Contena S, Delogu R, Zanetti S.

Acta Microbiol Immunol Hung. 2009 Dec;56(4):369-73. doi: 10.1556/AMicr.56.2009.4.6.

PMID:
20038488
48.

Phages specific for mycobacterial lipoarabinomannan help serodiagnosis of tuberculosis.

Bua A, Rosu V, Molicotti P, Das Gupta SK, Ahmed N, Zanetti S, Sechi LA.

New Microbiol. 2009 Jul;32(3):293-6.

49.

Heparin binding haemagglutin as potential diagnostic marker of Mycobacterium bovis.

Molicotti P, Bua A, Ortu S, Ladu MC, Delogu G, Mura A, Sechi LA, Fadda G, Zanetti S.

New Microbiol. 2008 Jul;31(3):423-7.

50.

Identification of mycobacterial infections in wild boars in Northern Sardinia, Italy.

Zanetti S, Bua A, Molicotti P, Delogu G, Mura A, Ortu S, Sechi LA.

Acta Vet Hung. 2008 Jun;56(2):145-52. doi: 10.1556/AVet.56.2008.2.1.

PMID:
18669241

Supplemental Content

Loading ...
Support Center